Preserving Mitochondrial Structure and Motility Promotes Recovery of White Matter After Ischemia.
Adenosine Triphosphate
/ biosynthesis
Aging
/ pathology
Animals
Axonal Transport
/ drug effects
Axons
/ drug effects
Calcium
/ metabolism
Drug Evaluation, Preclinical
Humans
Hypoxia-Ischemia, Brain
/ pathology
Ischemic Stroke
/ drug therapy
Mice
Mitochondria
/ drug effects
Mitochondrial Dynamics
/ drug effects
Mitochondrial Proteins
/ physiology
Nitric Oxide Synthase Type III
/ antagonists & inhibitors
Ornithine
/ analogs & derivatives
Quinazolinones
/ pharmacology
Reperfusion Injury
/ pathology
White Matter
/ drug effects
rho GTP-Binding Proteins
/ physiology
Ischemia
Miro-2
Mitochondria
Mitochondrial dynamics
NOS3
Stroke
Journal
Neuromolecular medicine
ISSN: 1559-1174
Titre abrégé: Neuromolecular Med
Pays: United States
ID NLM: 101135365
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
19
04
2019
accepted:
20
05
2019
pubmed:
4
6
2019
medline:
2
2
2021
entrez:
2
6
2019
Statut:
ppublish
Résumé
Stroke significantly affects white matter in the brain by impairing axon function, which results in clinical deficits. Axonal mitochondria are highly dynamic and are transported via microtubules in the anterograde or retrograde direction, depending upon axonal energy demands. Recently, we reported that mitochondrial division inhibitor 1 (Mdivi-1) promotes axon function recovery by preventing mitochondrial fission only when applied during ischemia. Application of Mdivi-1 after injury failed to protect axon function. Interestingly, L-NIO, which is a NOS3 inhibitor, confers post-ischemic protection to axon function by attenuating mitochondrial fission and preserving mitochondrial motility via conserving levels of the microtubular adaptor protein Miro-2. We propose that preventing mitochondrial fission protects axon function during injury, but that restoration of mitochondrial motility is more important to promote axon function recovery after injury. Thus, Miro-2 may be a therapeutic molecular target for recovery following a stroke.
Identifiants
pubmed: 31152363
doi: 10.1007/s12017-019-08550-w
pii: 10.1007/s12017-019-08550-w
pmc: PMC6884671
mid: NIHMS1530625
doi:
Substances chimiques
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone
0
Mitochondrial Proteins
0
Quinazolinones
0
N(G)-iminoethylornithine
36889-13-1
Adenosine Triphosphate
8L70Q75FXE
Ornithine
E524N2IXA3
Nitric Oxide Synthase Type III
EC 1.14.13.39
Nos3 protein, mouse
EC 1.14.13.39
RHOT2 protein, human
EC 3.6.1.-
rho GTP-Binding Proteins
EC 3.6.5.2
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
484-492Subventions
Organisme : NIA NIH HHS
ID : R01 AG033720
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS094881
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG033720
Pays : United States
Références
Science. 2003 Sep 19;301(5640):1677
pubmed: 14500967
Neuron. 2009 Feb 26;61(4):541-55
pubmed: 19249275
J Neurosci. 2001 Mar 15;21(6):1923-30
pubmed: 11245677
Brain Res. 2015 Sep 4;1619:155-65
pubmed: 25818100
J Neurosci. 2000 Dec 15;20(24):9235-41
pubmed: 11125001
J Neurosci. 2003 May 1;23(9):3826-36
pubmed: 12736353
J Cereb Blood Flow Metab. 2007 Sep;27(9):1540-52
pubmed: 17299453
Circulation. 2010 May 11;121(18):2012-22
pubmed: 20421521
Glia. 2014 Nov;62(11):1780-9
pubmed: 25043122
Neurol Res. 2016 Nov;38(11):1027-1034
pubmed: 30919739
J Neurosci. 1996 Jan 15;16(2):545-52
pubmed: 8551338
Trends Biochem Sci. 2001 Jan;26(1):23-9
pubmed: 11165513
Cell Calcium. 2010 Feb;47(2):150-7
pubmed: 20036774
Adv Exp Med Biol. 1999;468:97-107
pubmed: 10635022
Dev Cell. 2001 Oct;1(4):515-25
pubmed: 11703942
Brain Circ. 2018 Jul-Sep;4(3):84-94
pubmed: 30450413
Proc Natl Acad Sci U S A. 1990 Jun;87(11):4212-6
pubmed: 2349231
Stroke. 2002 Aug;33(8):2123-36
pubmed: 12154275
Cell. 2011 Nov 11;147(4):893-906
pubmed: 22078885
Invest Ophthalmol Vis Sci. 2011 Apr 27;52(5):2837-43
pubmed: 21372007
J Neurosci. 2009 Apr 29;29(17):5443-55
pubmed: 19403812
Clin Neurosci. 1997;4(5):246-50
pubmed: 9292251
EMBO J. 2009 Jun 3;28(11):1589-600
pubmed: 19360003
Brain Res Rev. 2011 Jun 24;67(1-2):103-18
pubmed: 21145355
Neuroscientist. 2009 Apr;15(2):126-33
pubmed: 19307420
Neurobiol Dis. 2019 Jun;126:47-61
pubmed: 29944965
J Neurosci. 2008 Feb 6;28(6):1479-89
pubmed: 18256269
Neurobiol Dis. 2007 Feb;25(2):284-90
pubmed: 17071096
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20728-33
pubmed: 19098100
J Cereb Blood Flow Metab. 2003 Mar;23(3):263-74
pubmed: 12621301
Mol Cell Biol. 2014 Apr;34(8):1412-26
pubmed: 24492963
J Neurochem. 2014 May;129(3):509-15
pubmed: 24147654
J Neurosci. 1994 Nov;14(11 Pt 1):6598-607
pubmed: 7965063
Stroke. 2017 Sep;48(9):2450-2456
pubmed: 28747462
J Neurosci. 2006 Jun 28;26(26):7035-45
pubmed: 16807333
Cells. 2015 Dec 31;5(1):
pubmed: 26729171
Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1066-1077
pubmed: 27836629
Neuron. 2005 Aug 4;47(3):379-93
pubmed: 16055062
J Neurosci. 2016 Sep 28;36(39):9990-10001
pubmed: 27683897
J Clin Invest. 2009 May;119(5):1275-85
pubmed: 19349686
Physiology (Bethesda). 2008 Apr;23:84-94
pubmed: 18400691
Cell Death Differ. 2012 Sep;19(9):1446-58
pubmed: 22388349
Adv Neurobiol. 2014;11:151-70
pubmed: 25236728
J Neurosci. 2010 Mar 24;30(12):4232-40
pubmed: 20335458
Development. 2016 Nov 15;143(22):4203-4213
pubmed: 27707795
Neuropharmacology. 2016 Nov;110(Pt B):626-632
pubmed: 26407763
Fortschr Neurol Psychiatr. 2010 Nov;78(11):652-7
pubmed: 21069630
Nat Rev Mol Cell Biol. 2010 Dec;11(12):872-84
pubmed: 21102612
Prog Neurobiol. 2016 Jun;141:45-60
pubmed: 27090751
J Neurosci. 1999 Jul 15;19(14):RC16
pubmed: 10407058
J Neurosci. 2011 Mar 16;31(11):3990-9
pubmed: 21411642
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5621-6
pubmed: 10792049
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3117-3127
pubmed: 28939434
J Cereb Blood Flow Metab. 1998 Jan;18(1):2-25
pubmed: 9428302
Cond Med. 2018;1(2):64-72
pubmed: 30135960
Nat Med. 1998 Mar;4(3):291-7
pubmed: 9500601
J Neurosci. 1993 Apr;13(4):1441-53
pubmed: 8096541
Cell. 2009 Jan 9;136(1):163-74
pubmed: 19135897
J Neurosci. 2018 Jul 11;38(28):6247-6266
pubmed: 29891729
Neurotherapeutics. 2013 Oct;10(4):798-807
pubmed: 23881453
PLoS One. 2017 Oct 2;12(10):e0185764
pubmed: 28968439
J Neurosci. 2001 Jun 15;21(12):4237-48
pubmed: 11404409
Neuron. 2003 Sep 25;40(1):53-63
pubmed: 14527433
Curr Mol Med. 2004 Mar;4(2):113-30
pubmed: 15032708
Prog Neurobiol. 2017 Oct;157:92-116
pubmed: 27321753
J Neurophysiol. 1995 Jul;74(1):369-77
pubmed: 7472338
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Neurosci Lett. 2018 Nov 20;687:37-42
pubmed: 30125643
J Gerontol A Biol Sci Med Sci. 2015 Nov;70(11):1355-9
pubmed: 25631392
J Anat. 2011 Jul;219(1):53-64
pubmed: 21250988